![Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats | npj Parkinson's Disease Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-019-0096-2/MediaObjects/41531_2019_96_Fig1_HTML.png)
Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats | npj Parkinson's Disease
Clinical Study L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa
![Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-015-1449-6/MediaObjects/702_2015_1449_Fig2_HTML.gif)
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink
![Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program](https://www.frontiersin.org/files/Articles/1036068/fneur-13-1036068-HTML/image_m/fneur-13-1036068-t001.jpg)
Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
![Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program](https://www.frontiersin.org/files/Articles/1036068/fneur-13-1036068-HTML/image_m/fneur-13-1036068-g001.jpg)
Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
![Molecules | Free Full-Text | Electrochemical Sensor Based on Multi-Walled Carbon Nanotubes and N-Doped TiO2 Nanoparticles for Voltametric Simultaneous Determination of Benserazide and Levodopa Molecules | Free Full-Text | Electrochemical Sensor Based on Multi-Walled Carbon Nanotubes and N-Doped TiO2 Nanoparticles for Voltametric Simultaneous Determination of Benserazide and Levodopa](https://www.mdpi.com/molecules/molecules-27-08614/article_deploy/html/images/molecules-27-08614-g001-550.jpg)
Molecules | Free Full-Text | Electrochemical Sensor Based on Multi-Walled Carbon Nanotubes and N-Doped TiO2 Nanoparticles for Voltametric Simultaneous Determination of Benserazide and Levodopa
Decentralised Procedure Public Assessment Report Levobens-TEVA 100/25 mg Tabletten Levobens-TEVA 200/50 mg Tabletten Levodopa, B
![Леводопа/Бенсеразид-Тева таб. 200мг+50мг №100 (Тева Чешские Предприятия с.р.о.) купить в Москве по низкой цене в интернет аптеке Ригла | код товара:101486 Леводопа/Бенсеразид-Тева таб. 200мг+50мг №100 (Тева Чешские Предприятия с.р.о.) купить в Москве по низкой цене в интернет аптеке Ригла | код товара:101486](https://cdn.rigla.ru/media/catalog/product/cache/1e8ef93b9b4867ab9f3538dde2cb3b8a/1/0/101486-2-a-2-a-2a2acf71cc9d05498af57668d3db2db96af323fd_101486.jpg)
Леводопа/Бенсеразид-Тева таб. 200мг+50мг №100 (Тева Чешские Предприятия с.р.о.) купить в Москве по низкой цене в интернет аптеке Ригла | код товара:101486
![PDF) Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: A case series PDF) Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: A case series](https://www.researchgate.net/profile/Robert-Hauser-2/publication/38012326/figure/tbl1/AS:601799115419668@1520491498533/Summary-of-case-reports-of-four-patients-with-Parkinsons-disease-switched-to-LCE-200_Q320.jpg)
PDF) Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: A case series
![Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/270172/f/1.png)
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
![Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease - Leta - 2023 - European Journal of Neurology - Wiley Online Library Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease - Leta - 2023 - European Journal of Neurology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d318886f-f599-401e-ab96-e9e709ad8c68/ene15734-fig-0004-m.jpg)
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease - Leta - 2023 - European Journal of Neurology - Wiley Online Library
![Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-009-0344-4/MediaObjects/702_2009_344_Fig1_HTML.gif)